9 completed. 9 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 9 | Completed 9 |
Follow Maruho Co., Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety and Efficacy of CLS006 Versus Vehicle in Subjects 2 Years of Age or Older With Cutaneous Common Warts CLS006, CLS006 Vehicle - Cutaneous Common Warts | Phase 3 | Completed | Maruho Co., Ltd. | 491 | 2017-10-30 | 2023-09-14 |
| A Phase 3 Study to Evaluate the Efficacy and Safety of CLS006 Versus Vehicle in Subjects 2 Years of Age or Older With Cutaneous Common Warts CLS006 (Furosemide) Topical Gel, Vehicle Topical Gel - Cutaneous Common Warts | Phase 3 | Completed | Maruho Co., Ltd. | 484 | 2017-01-01 | 2023-09-14 |
| Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle CLS001 (Omiganan), Vehicle - Rosacea | Phase 3 | Completed | Maruho Co., Ltd. | 463 | 2015-12-01 | 2022-08-02 |
| Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle CLS001 (Omiganan), Vehicle - Rosacea | Phase 3 | Completed | Maruho Co., Ltd. | 263 | 2015-10-01 | 2022-08-02 |
| Study to Evaluate the Long-term Safety of a Once-Daily Omiganan Topical Gel Omiganan - Rosacea | Phase 3 | Completed | Maruho Co., Ltd. | 307 | 2015-10-01 | 2022-07-19 |
| Open-label Study of ASP2151 in Herpes Simplex Patients ASP2151 - Herpes Simplex | Phase 3 | Completed | Maruho Co., Ltd. | 275 | 2013-11-01 | 2024-09-27 |
| Efficacy Study Comparing Topical M518101 and Vitamin D3 in Adult Psoriasis Patients M518101 - Plaque Psoriasis | Phase 3 | Completed | Maruho Europe Limited | 788 | 2013-10-01 | 2015-12-31 |
| Phase III Study of ASP2151 in Herpes Zoster Patients ASP2151, valaciclovir - Herpes Zoster | Phase 3 | Completed | Maruho Co., Ltd. | 751 | 2013-08-01 | 2018-11-27 |
| Phase III Study of ASP2151 in Herpes Simplex Patients ASP2151, ASP2151 placebo - Herpes Simplex | Phase 3 | Completed | Maruho Co., Ltd. | 468 | 2013-08-01 | 2024-10-09 |
Rosacea (3) · Herpes Simplex (2) · Herpes Zoster (1) · Psoriasis (1)
ASP2151 (3) · Omiganan (3) · Cholecalciferol (1) · Furosemide (1) · Gels (1) · Valacyclovir (1)
United States (5) · Australia (3) · Canada (3) · France (3) · Germany (3) · Japan (3) · Netherlands (3) · New Zealand (3) · Sweden (3) · United Kingdom (3) · Austria (1) · Bulgaria (1) · Hungary (1) · Lithuania (1) · Poland (1)
D Thaci, Prof.Dr (1) · Maruho Co.,Ltd. Kyoto R&D Center (1)